487 related articles for article (PubMed ID: 33806009)
1. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.
Choromańska A; Chwiłkowska A; Kulbacka J; Baczyńska D; Rembiałkowska N; Szewczyk A; Michel O; Gajewska-Naryniecka A; Przystupski D; Saczko J
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806009
[TBL] [Abstract][Full Text] [Related]
2. Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies.
Bernardes N; Fialho AM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518103
[TBL] [Abstract][Full Text] [Related]
3. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
[TBL] [Abstract][Full Text] [Related]
4. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.
Borrelli A; Tornesello AL; Tornesello ML; Buonaguro FM
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385037
[TBL] [Abstract][Full Text] [Related]
5. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Deacon JC; Engelman DM; Barrera FN
Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
[TBL] [Abstract][Full Text] [Related]
6. Lipids as a target for drugs modulating multidrug resistance of cancer cells.
Hendrich AB; Michalak K
Curr Drug Targets; 2003 Jan; 4(1):23-30. PubMed ID: 12528987
[TBL] [Abstract][Full Text] [Related]
7. Plasma membrane ion channels and epithelial to mesenchymal transition in cancer cells.
Azimi I; Monteith GR
Endocr Relat Cancer; 2016 Nov; 23(11):R517-R525. PubMed ID: 27619258
[TBL] [Abstract][Full Text] [Related]
8. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
9. Physical Methods for Drug and Gene Delivery Through the Cell Plasma Membrane.
Jakutavičiūtė M; Ruzgys P; Tamošiūnas M; Maciulevičius M; Šatkauskas S
Adv Anat Embryol Cell Biol; 2017; 227():73-92. PubMed ID: 28980041
[TBL] [Abstract][Full Text] [Related]
10. Cyclic gomesin, a stable redesigned spider peptide able to enter cancer cells.
Benfield AH; Defaus S; Lawrence N; Chaousis S; Condon N; Cheneval O; Huang YH; Chan LY; Andreu D; Craik DJ; Henriques ST
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183480. PubMed ID: 32979382
[TBL] [Abstract][Full Text] [Related]
11. Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy.
Cheng H; Fan JH; Zhao LP; Fan GL; Zheng RR; Qiu XZ; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Aug; 211():14-24. PubMed ID: 31078049
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy.
Szlasa W; Kiełbik A; Szewczyk A; Novickij V; Tarek M; Łapińska Z; Saczko J; Kulbacka J; Rembiałkowska N
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681903
[TBL] [Abstract][Full Text] [Related]
13. Membrane blebbing as a recovery manoeuvre in site-specific sonoporation mediated by targeted microbubbles.
Leow RS; Wan JM; Yu AC
J R Soc Interface; 2015 Apr; 12(105):. PubMed ID: 25694544
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
Panzarini E; Dini L
Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
[TBL] [Abstract][Full Text] [Related]
15. Recognition Sites for Cancer-targeting Drug Delivery Systems.
Guan S; Zhang Q; Bao J; Hu R; Czech T; Tang J
Curr Drug Metab; 2019; 20(10):815-834. PubMed ID: 31580248
[TBL] [Abstract][Full Text] [Related]
16. Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis.
Tashima T
Bioorg Med Chem Lett; 2018 Oct; 28(18):3015-3024. PubMed ID: 30031619
[TBL] [Abstract][Full Text] [Related]
17. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
18. Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.
Zhu Y; Cui H; Zhang J; Bei Y; Huang Y; Li M; Liu J; Wu Y; Gao J
Mini Rev Med Chem; 2023; 23(15):1535-1559. PubMed ID: 36740792
[TBL] [Abstract][Full Text] [Related]
19. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
20. Drug targeting opportunities en route to Ras nanoclusters.
Pavic K; Chippalkatti R; Abankwa D
Adv Cancer Res; 2022; 153():63-99. PubMed ID: 35101236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
